
Al Harrington Champions Cannabis Science After NBA Recovery Journey
Former NBA star Al Harrington has shifted his cannabis advocacy from celebrity branding to demanding scientific rigor, partnering with Avicanna to champion research-driven recovery solutions for athletes and consumers
Key Points
- 1Al Harrington endured 12 surgeries during his 16-season NBA career and turned to cannabis for recovery
- 2He emphasizes the need for long-term, evidence-based solutions rather than just return-to-play protocols
- 3Harrington partnered with Avicanna, whose clinical trials demonstrated significant improvements in pain management
- 4His personal experience, including his grandmother’s medical use of cannabis, shaped his advocacy for rigorous research
- 5Harrington calls for greater technical credibility and intention in cannabis wellness products
After enduring 12 surgeries and 16 seasons in the NBA, Al Harrington emerged from professional basketball not just as a cannabis advocate, but as a demanding consumer who questions the science behind wellness products. Unlike many former athletes who leverage their fame into celebrity-backed cannabis brands, Harrington’s journey has been shaped by a personal quest for credible, long-term recovery solutions. "What frustrated me most was how little focus there was on the long-term," Harrington told High Times, highlighting the lack of attention to post-career health in traditional sports medicine
Harrington’s interest in cannabis began as a means of relief during his rehabilitation, but it quickly evolved into a deeper investigation into how the plant interacts with the body. He noticed benefits that extended beyond pain relief, sparking curiosity about the mechanisms at work. "Once it became part of my daily routine, I started noticing benefits that went beyond a specific injury," he explained. This curiosity led him to scrutinize not just the products, but the science and research supporting them
A pivotal moment in Harrington's exploration came when he connected with Avicanna, a Toronto-based biopharmaceutical company specializing in cannabinoid research and innovation. Avicanna’s commitment to rigorous pre-clinical and clinical trials, including a real-world study showing a 35.4% improvement in musculoskeletal pain after one month, impressed Harrington and shifted his focus away from superficial wellness trends. "Hearing about clinical trials and seeing real data made me realize it was more than just a trend," he said. Avicanna’s patented transdermal delivery technology and international reach further validated his search for evidence-based solutions
Harrington’s credibility in the cannabis space is rooted in personal experience and family history as much as his professional career. He founded Viola, a brand inspired by his grandmother’s positive experience with medical cannabis, which transformed his own views on the plant. "Growing up, I was always told cannabis was a gateway drug. That mindset stuck with me for a long time. But when I saw how it helped my grandmother medically, it completely shifted my perspective," Harrington shared, emphasizing that his advocacy is grounded in skepticism and a demand for proof
His approach stands in stark contrast to an industry often criticized for prioritizing marketing over substance. Harrington is vocal about the need for rigorous standards, saying, "Doing it right means having intention behind it. You need a real plan for what you’re trying to address and how cannabis fits into your overall wellness." According to High Times, his insistence on technical credibility and real-world efficacy sets a new benchmark for athlete-founded brands, as he calls for more science-backed innovation and less hype-driven noise
From the OG Lab newsroom perspective, Harrington’s evolution from athlete to evidence-seeking cannabis entrepreneur underscores a critical shift in the industry. As consumer expectations rise and regulatory scrutiny increases, brands that invest in genuine research and transparency are poised to gain trust and longevity. Harrington’s story highlights the growing demand for proof over promotion—a trend that could define the next era in cannabis wellness


